Epidermolytic hyperkeratosis 2A, autosomal dominant: genes and variants
Explore variant evidence for Epidermolytic hyperkeratosis 2A, autosomal dominant across 2 analyzed proteins (KRT10, KRT1). Linked ClinVar records include 11 pathogenic or likely pathogenic variants, 2 variants of uncertain significance and 0 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Epidermolytic hyperkeratosis 2A, autosomal dominant
KRT10: Keratin, type I cytoskeletal 10
It forms intermediate filaments with keratin 1 in differentiating epidermal keratinocytes, protecting the upper epidermis from mechanical stress. Dominant pathogenic variants cause epidermolytic ichthyosis, while specific mechanisms can produce ichthyosis with confetti.
7 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in KRT10 have source records linked to Epidermolytic hyperkeratosis 2A, autosomal dominant. Association strength is not clinical gene validity.
KRT1: Keratin, type II cytoskeletal 1
It pairs with keratin 10 to provide mechanical resilience to suprabasal epidermal cells and help maintain the skin barrier. Dominant pathogenic variants cause epidermolytic ichthyosis and related palmoplantar keratoderma phenotypes.
4 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in KRT1 have source records linked to Epidermolytic hyperkeratosis 2A, autosomal dominant. Association strength is not clinical gene validity.
Where Epidermolytic hyperkeratosis 2A, autosomal dominant variants cluster
- KRT10 Coil 1A (positions 146–181): 5 of 7 ClinVar pathogenic / likely pathogenic variants, 11.6× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Epidermolytic hyperkeratosis 2A, autosomal dominant
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| KRT10 R156H | 156 | IF rod | Pathogenic / likely pathogenic (★★★★) |
| KRT1 L187F | 187 | IF rod | Pathogenic / likely pathogenic (★★) |
| KRT1 E478G | 478 | IF rod | Pathogenic / likely pathogenic (★) |
| KRT1 E478Q | 478 | IF rod | Pathogenic / likely pathogenic (★) |
| KRT1 L187P | 187 | IF rod | Pathogenic / likely pathogenic |
| KRT10 M150R | 150 | IF rod | Pathogenic / likely pathogenic |
| KRT10 N154H | 154 | IF rod | Pathogenic / likely pathogenic |
| KRT10 Y160D | 160 | IF rod | Pathogenic / likely pathogenic |
| KRT10 L161S | 161 | IF rod | Pathogenic / likely pathogenic |
| KRT10 K439E | 439 | IF rod | Pathogenic / likely pathogenic |
| KRT10 L442Q | 442 | IF rod | Pathogenic / likely pathogenic |
Which prediction tools work for Epidermolytic hyperkeratosis 2A, autosomal dominant
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 100 out of 100
- PolyPhen-2: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 97 out of 100
- SIFT: 96 out of 100
Same protein, different disease
- Annular epidermolytic ichthyosis also has ClinVar records linked to KRT1 variants; they fall partly in the same places as the Epidermolytic hyperkeratosis 2A, autosomal dominant variants (5 pathogenic / likely pathogenic).
- Epidermolytic ichthyosis also has ClinVar records linked to KRT1 variants; they fall mostly in different places as the Epidermolytic hyperkeratosis 2A, autosomal dominant variants (5 pathogenic / likely pathogenic).
Diseases related to Epidermolytic hyperkeratosis 2A, autosomal dominant
- Epidermolytic palmoplantar keratoderma, also linked to KRT1 and KRT10
- Annular epidermolytic ichthyosis, also linked to KRT1 and KRT10
- Epidermolytic ichthyosis, also linked to KRT1 and KRT10
- Ichthyosis, annular epidermolytic, also linked to KRT1 and KRT10
- Pachyonychia congenita, also linked to KRT10
- Ichthyosis and erythrokeratoderma, also linked to KRT10
- Autosomal dominant epidermolytic ichthyosis, also linked to KRT10
- Epidermolytic nevus, also linked to KRT10
- Palmoplantar keratoderma, bothnian, also linked to KRT1
- Keratosis palmoplantaris striata, also linked to KRT1
Frequently asked questions
Which genes have records linked to Epidermolytic hyperkeratosis 2A, autosomal dominant?
This view contains 2 analyzed proteins: KRT10, KRT1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 11 pathogenic or likely pathogenic variants, 2 variants of uncertain significance and 0 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 20 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center